P M Wilkinson

5.0k citations

87 papers · 3.4k indexed · 1 hit paper · h-index 31

Impact in

Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Oncology top 2%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies

Papers in

Reproductive Medicine 14
- Ovarian cancer diagnosis and treatment 13
Oncology 32
- Cancer Treatment and Pharmacology 15
- Lung Cancer Research Studies 7

Co-authors: Gavin Manmathan R.D. James Peter Canney Michael Moore Sally Stenning Graham M. Mead Sophie D. Fosså Mervyn Israel
Journals: British Journal of Cancer (17 papers)Cancer Chemotherapy and Pharmacology (10 papers)Journal of Clinical Oncology (8 papers)Cancer (3 papers)Clinical Radiology (3 papers)
Partner nations: United Kingdom United States Norway

In The Last Decade

P M Wilkinson

86 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Primary prevention of cardiovascular disease: A review of contemporary guidance and literature 2017 · 330 citations

Peers

Countries citing papers authored by P M Wilkinson

Since Specialization

Citations

This map shows the geographic impact of P M Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P M Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P M Wilkinson more than expected).

Fields of papers citing papers by P M Wilkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P M Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P M Wilkinson. The network helps show where P M Wilkinson may publish in the future.

Co-authors

The 25 scholars most cited alongside P M Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P M Wilkinson Line = papers co-authored together P M Wilkinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer British Journal of Cancer ·(unknown), Rahmath Fida, Johanna Mäenpää, Derek Cruickshank, Jonathan A. Ledermann, P M Wilkinson, Richard Welch, Stephen Chan, P. Vasey, Bengt Sorbe, Andrew Hindley, Gordon C. Jayson	2005	8
2	The level of haemoglobin in anaemic cancer patients correlates positively with quality of life British Journal of Cancer ·M. Lind, C. C. Vernon, Deborah Cruickshank, P M Wilkinson, Tim Littlewood, N Stuart, Crispin Jenkinson, Messay Tesfaye Demissie, Helen Doll, D Wild	2002	91
3	A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting Supportive Care in Cancer ·A. A. Fauser, Giorgio Pizzocaro, Katherine Lemons, D. Khayat, P M Wilkinson	2000	19
4	A Doxorubicin-Based Regimen used in the Treatment of Elderly Patients with High-Grade Non-Hodgkin's Lymphoma Clinical Oncology ·J. Wylie, Richard Cowan, John Radford, D.P. Deakin, Switzerland Month, P M Wilkinson	2000	1
5	High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity Annals of Oncology ·M. Decatris, P M Wilkinson, Richard Welch, Marlen Metzner, G.R. Morgenstern, Jiunn Hong Po	2000	30
6	Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours British Journal of Cancer ·Sophie D. Fosså, Sally Stenning, A. Gerl, Josh Hanson, Peter Clark, P M Wilkinson, William G. Jones, M.V. Williams, R.T.D. Oliver, ES Newlands, Cornelius Zhao, M.H. Cullen, Stuart Kaye, Gordon Rustin, Pat Cook	1999	89
7	Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. Journal of Clinical Oncology ·Ruth Pettengell, John Radford, G.R. Morgenstern, J.H. Scarffe, Martin Harris, Penella J. Woll, D.P. Deakin, Robert E. J. Ryder, P M Wilkinson, D. Crowther	1996	69
8	Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease. Journal of Clinical Oncology ·John Radford, D Crowther, A. Z. S. Rohatiner, Fatchul Lutfah, Karol Najdek, Amit M. Oza, D.P. Deakin, S.J. Arnott, P M Wilkinson, R.D. James	1995	35
9	Recombinant Human Erythropoietin in Patients with Ovarian Carcinoma and Anaemia Secondary to Cisplatin and Carboplatin Chemotherapy: Preliminary Results Acta Haematologica ·R.D. James, P M Wilkinson, Filiberto Belli, Richard Welch, Richard Cowan	1992	26
10	The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. Journal of Clinical Oncology ·Graham M. Mead, Sally Stenning, M C Parkinson, A. Horwich, Sophie D. Fosså, P M Wilkinson, Stan B. Kaye, E.S. Newlands, Pat Cook	1992	131
11	An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP Annals of Oncology ·Malcolm Ranson, John Radford, R. Swindell, D.P. Deakin, P M Wilkinson, Martin Harris, Richard J. Johnson, D Crowther	1991	9
12	A single-dose-finding study of the antiemetic effect and associated plasma levels of MDL 72222 in patients receiving cisplatin Cancer Chemotherapy and Pharmacology ·J Bann, P M Wilkinson, Klaus D. Haegele, P Citra Kharisma	1991	4
13	A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer Clinical Radiology ·高田英俊, R. C. S. Pointon, P M Wilkinson	1987	87
14	A simple quantitative HPLC assay for ifosfamide in biological fluids Biomedical Chromatography ·Keith Featherstone, P M Wilkinson, T. Cerny, N. Thatcher	1986	27
15	Prospective study of follow up alone in stage I teratoma of the testis. BMJ ·G. Read, Richard J. Johnson, P M Wilkinson, B Eddleston	1983	46
16	Levonantradol effectiveness in cancer patients resistant to conventional anti-emetics. PubMed ·Katherine E. Hess, P M Wilkinson	1982	6
17	Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man British Journal of Cancer ·J. Németh, N. Thatcher, Peter W. Mullen, G. N. Smith, P M Wilkinson	1979	2
18	Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Mervyn Israel, P M Wilkinson, William J. Pegg, Emil Frei	1978	41
19	Urinary anthracycline metabolites from mice treated with adriamycin and N-trifluoroacetyladriamycin-14-valerate. Journal of Pharmacology and Experimental Therapeutics ·Mervyn Israel, William J. Pegg, P M Wilkinson	1978	22
20	THE PERSISTENCE OF ADRIAMYCIN IN MAN AND RAT British Journal of Clinical Pharmacology ·P M Wilkinson, G. E. Mawer	1974	33

About P M Wilkinson

P M Wilkinson is a scholar working on Reproductive Medicine, Oncology, Pathology and Forensic Medicine, Neurology and Genetics, having authored 87 papers that have together received 3.4k indexed citations. Recurring topics across this work include Testicular diseases and treatments (16 papers), Cancer Treatment and Pharmacology (15 papers), Lymphoma Diagnosis and Treatment (15 papers), Ovarian cancer diagnosis and treatment (13 papers), Lung Cancer Treatments and Mutations (8 papers), Neuroblastoma Research and Treatments (7 papers), Lung Cancer Research Studies (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Reproductive Medicine (603 citations), Oncology (1.0k citations), Pathology and Forensic Medicine (607 citations), Hematology (332 citations) and Genetics (287 citations). P M Wilkinson has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include Gavin Manmathan, R.D. James, Peter Canney, Michael Moore, Sally Stenning, Graham M. Mead, Sophie D. Fosså, Mervyn Israel, William J. Pegg and Pat Cook. Their work appears in journals such as British Journal of Cancer, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Cancer and Clinical Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact